News|Videos|September 13, 2023
Interview with Piramal’s Peter DeYoung at DCAT
Author(s)Piramal Pharma Solutions
Advertisement
Key Learning Objectives
- Demonstrate expertise in key areas of drug substance & drug product development and manufacturing with emphasis on APIs and ADCs
- Piramal is expanding to meet current and future market demand
- Piramal is a leader in integrated solutions with 15 sites in NA, EU and India
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Rasonque's 60% Survival Benefit: What It Means for Oncology Pipelines
2
3D Printing Revolutionizing Tissue Engineering and Regenerative Medicine in Europe
3
What the McKesson-Precision Medicine Deal Signals for Trial Sponsors
4
Pharma's Next AI Problem Is Authority
5